Skip to main content
. 2024 Jun 7;13(11):e7330. doi: 10.1002/cam4.7330

TABLE 2.

Univariate analysis for anxiety and depression.

Variables Anxiety n (%) p‐Value Depression n (%) p‐Value
No Yes No Yes
Total, n 335 (73.8) 119 (26.2) 317 (69.8) 137 (30.2)
Age, a years 57.5 (11.3) 55.2 (11.4) 0.059 57.2 (11.4) 56.2 (11.3) 0.420
Gender
Female 138 (41.2) 52 (43.7) 0.634 133 (42.0) 57 (41.6)
Male 197 (58.8) 67 (56.3) 184 (58.0) 80 (58.4)
Marital status
Married 321 (95.8) 113 (95.0) 0.694 306 (96.5) 128 (93.4) 0.140
Single b 14 (4.2) 6 (5.0) 11 (3.5) 9 (6.6)
Education
≤9 years 170 (50.7) 57 (47.9) 0.594 157 (49.5) 70 (51.1) 0.759
≥10 years 165 (49.3) 62 (52.1) 160 (50.5) 67 (48.9)
ECOG PS c
0 and 1 277 (82.7) 91 (76.5) 0.137 264 (83.3) 104 (75.9) 0.066
2 58 (17.3) 28 (23.5) 53 (16.7) 33 (24.1)
Disease stage
No evidence of disease 13 (3.9) 7 (5.9) <0.001 13 (4.1) 7 (5.1) <0.001
Locoregional 108 (32.2) 72 (60.5) 102 (32.2) 78 (56.9)
Locoregional plus metastatic 7 (2.1) 4 (3.4) 8 (2.5) 3 (2.2)
Metastatic 207 (61.8) 36 (30.3) 194 (61.2) 49 (35.8)
Disease status
Complete remission 6 (1.8) 10 (8.4) <0.001 5 (1.6) 11 (8.0) <0.001
Partial remission 60 (17.9) 44 (37.0) 57 (18.0) 47 (34.3)
Stable disease 165 (49.3) 36 (30.3) 162 (51.1) 39 (28.5)
Progressive disease 71 (21.2) 22 (18.5) 62 (19.6) 31 (22.6)
Unclear 33 (9.9) 7 (5.9) 31 (9.8) 9 (6.6)
Current cancer therapy
Palliative care 121 (36.1) 62 (52.1) 0.002 105 (33.1) 78 (56.9) <0.001
Anticancer therapy 214 (63.9) 57 (47.9) 212 (66.9) 59 (43.1)
Symptom burden a 18.29 (16.32) 43.20 (22.10) <0.001 17.85 (16.55) 40.95 (21.61) <0.001

Note: Significance level at p < 0.05.

a

Using mean (SD).

b

Including divorced or windowed.

c

For Eastern Cooperative Oncology Group performance status.